Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

Blauvelt Andrew; Papp Kim A.; Lebwohl Mark G.; Green Lawrence J.; Hsu Sylvia; Bhatt Varsha; Rastogi Shipra; Pillai Radhakrishnan; Israel Robert

首页> 外文期刊>Journal of the American Academy of Dermatology >Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

【24h】

Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

机译：用Brodalumab治疗中度至严重的牛皮癣患者的快速发作：来自两相3阶段随机临床试验的数据汇总分析（Amagine-2和Amagine-3）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the American Academy of Dermatology》 |2017年第2期|共4页
作者
Blauvelt Andrew; Papp Kim A.; Lebwohl Mark G.; Green Lawrence J.; Hsu Sylvia; Bhatt Varsha; Rastogi Shipra; Pillai Radhakrishnan; Israel Robert;
展开▼
作者单位

Oregon Med Res Ctr 9495 SW Locust St Suite G Portland OR 97223 USA;

Prob Med Res Waterloo ON Canada;

Icahn Sch Med Mt Sinai New York NY 10029 USA;

Temple Univ Dept Dermatol Philadelphia PA 19122 USA;

Baylor Coll Med Dept Dermatol Houston TX 77030 USA;

Dow Pharmaceut Sci Petaluma CA USA;

Valeant Pharmaceut North Amer LLC Bridgewater NJ USA;

Dow Pharmaceut Sci Petaluma CA USA;

Valeant Pharmaceut North Amer LLC Bridgewater NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3) [J] . Blauvelt Andrew, Papp Kim A., Lebwohl Mark G., Journal of the American Academy of Dermatology . 2017,第2期

机译：用Brodalumab治疗中度至严重的牛皮癣患者的快速发作：来自两相3阶段随机临床试验的数据汇总分析（Amagine-2和Amagine-3）
2. Rapid onset of efficacy in patients with psoriasis treated with ixekizumab: A pooled analysis of data from two phase 3 randomized clinical trials (UNCOVER-2 and UNCOVER-3) [J] . Leonardi C. L., Langley R., Blauvelt A., Experimental dermatology . 2017,第3期

机译：用Ixekizumab治疗牛皮癣患者的疗效快速发作：来自两阶段3阶段随机临床试验的数据汇总分析（揭露-2和未发现-3）
3. RAPID ONSET OF EFFICACY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH IXEKIZUMAB: A POOLED ANALYSIS OF DATA FROM TWO PHASE III CLINICAL TRIALS [J] . Deodhar A., Papp K., Shuler C. L., Clinical and experimental rheumatology . 2018,第4期

机译：用Ixekizumab处理的活性银屑病关节炎患者疗效快速发作：来自两期III期临床试验的数据汇总分析
4. A Framework for Patient Data Management and Analysis in Randomised Clinical Trials [C] . Pietro Hiram Guzzi, Tiziana Larussa, Rosarina Vallelunga, IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：随机临床试验中患者数据管理和分析的框架
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Incidence rates of inflammatory bowel disease in patients with psoriasis psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials [O] . Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, -1

机译：苏金单抗治疗牛皮癣牛皮癣性关节炎和强直性脊柱炎的炎症性肠病的发生率：对21项临床试验汇总数据的回顾性分析
7. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3 [O] . K.A. Papp, K.B. Gordon, R.G. Langley, 2018

机译：先前生物用法对患有中度至重度斑块牛皮癣患者的Brodalumab和Ustekumab的疗效和安全性的影响：随机对照试验Amagine-2和Amagine-3的综合分析

Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

著录项

相似文献

相关主题

期刊订阅